Recent progress in the development of plant derived vaccines

Area of Science:

• Biotechnology
• Vaccinology
• Plant molecular farming

Background:

• Recombinant subunit vaccines have utilized diverse production systems for three decades.
• Plant-based systems are emerging as a viable platform for biopharmaceutical production, particularly for vaccines.

Purpose of the Study:

• To evaluate the advantages of plant-based vaccine production systems.
• To discuss the cost, safety, and scalability of plant-derived vaccines.
• To assess the impact of plant systems on the broader vaccine industry.

Main Methods:

• Review of existing literature on recombinant protein expression in plants.
• Analysis of clinical trial data for plant-based vaccines.
• Evaluation of economic and safety profiles of plant production platforms.

Main Results:

• Plants offer a cost-effective, safe, and scalable method for producing recombinant vaccines.
• Successful clinical trials demonstrate the efficacy and feasibility of plant-based vaccine candidates.
• Plant systems present significant potential to reshape vaccine manufacturing and accessibility.

Conclusions:

• Plant-based vaccine production is a promising and increasingly validated approach.
• The unique advantages of plants address key challenges in traditional vaccine manufacturing.
• Further development and adoption of plant systems are expected to significantly influence the future of vaccinology.